Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
01/07/1991 | CA2035868A1 Hybrid molecules |
01/06/1991 | WO1991000743A1 Method for determining oncogenic potential of a chemical compound |
01/06/1991 | CA2035464A1 Method for determining oncogenic potential of a chemical compound |
01/06/1991 | CA2020544A1 Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application |
01/06/1991 | CA2020543A1 Monoclonal antibodies directed against activated microglia cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications |
01/06/1991 | CA2020303A1 Cytokines |
01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
01/04/1991 | CA2020305A1 Production of acidic fgf protein |
01/03/1991 | DE3920826A1 Prodn. of recombinant metallo-thionein proteins - and prodn. of apo-thionein proteins, and use as antiinflammatory agents |
01/03/1991 | DE3920753A1 New plasmid contg. complete CDNA of human rhinovirus 2 |
01/03/1991 | DE3920282A1 DNA encoding TNF binding protein and TNF- receptor |
01/03/1991 | CA2009336A1 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
01/02/1991 | EP0406216A2 Protein-S-containing pharmaceutical preparation |
01/02/1991 | EP0406122A1 Process for obtaining a native, wild-type human oestrogen receptor and its applications |
01/02/1991 | EP0406029A1 Fungal stress proteins |
01/02/1991 | EP0405998A1 Antibiotic agents |
01/02/1991 | EP0405997A1 Antibiotic agent |
01/02/1991 | EP0405980A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
01/02/1991 | EP0405867A1 Novel compounds |
01/02/1991 | EP0405858A2 Control of aberrant expression vector accumulation during fermentation procedures |
01/02/1991 | EP0405810A2 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
01/02/1991 | EP0405763A1 GRF peptides |
01/02/1991 | EP0405656A1 Hair growth composition |
01/02/1991 | EP0405484A1 A physiologically active substance derived of malt and process for the production thereof |
01/02/1991 | EP0405467A2 A process for the determination of interleukins |
01/02/1991 | EP0405463A2 Supporting agents for anti-cancer therapy |
01/02/1991 | EP0405242A2 VIP-Analogs II |
01/02/1991 | EP0404912A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
01/02/1991 | EP0404824A1 Ribosome binding site |
01/02/1991 | EP0404812A1 Recombinant igf binding protein (ibp-1) |
01/02/1991 | CA1278650C Process for the low-racemization preparation of peptide intermediates of the synthesis of gonadorelin and gonadorelin analogs, and new intermediates for this process |
01/02/1991 | CA1278540C Modified antibiotic resistance gene |
01/02/1991 | CA1278513C Canine parvovirus vaccines |
01/01/1991 | USH875 Toxin-encoding nucleic acid fragments derived from a Bacillus thuringiensis subsp. israelensis gene |
01/01/1991 | US4981979 Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
01/01/1991 | US4981961 Chemically-stable chromatography adsorber; modifying nucleophilic polymers with pyridine bases |
01/01/1991 | US4981956 DNA sequences encoding bovine growth factors |
01/01/1991 | US4981953 Antitumor |
01/01/1991 | US4981952 Method for the purification of vitamin K-dependent proteins |
01/01/1991 | US4981951 Sugars, hemagglutins |
01/01/1991 | US4981950 Hypotensive |
01/01/1991 | US4981843 N-heterocyclic alcohol derivatives |
01/01/1991 | US4981799 Acylamino acid racemase, production and use thereof |
01/01/1991 | US4981790 Genetic engineering |
01/01/1991 | US4981784 Retinoic acid receptor method |
01/01/1991 | US4981782 Synthetic peptides for diagnosis and prevention of influenza virus infection and their use |
12/31/1990 | WO1991000350A1 Nonglycosylated human interleukin-3 analog proteins |
12/31/1990 | WO1991000296A1 Enzymatically binding bioactive materials to proteins |
12/31/1990 | WO1991000287A1 Enhancement of musculature in animals |
12/31/1990 | CA2063434A1 Enzymatically binding bioactive materials to proteins |
12/31/1990 | CA2033182A1 Nonglycosylated human interleukin-3 analog proteins |
12/31/1990 | CA2020198A1 Human and mouse retinoic acid receptors and genes encoding for them |
12/31/1990 | CA2020063A1 Antibiotic agent |
12/31/1990 | CA2019970A1 Vip-analogs ii |
12/31/1990 | CA2019408A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same |
12/30/1990 | WO1991000293A1 Vasodilatory and immune suppressant peptides |
12/30/1990 | WO1991000104A1 Production of virus and purification of viral envelope proteins for vaccine use |
12/30/1990 | WO1991000014A1 Improved biological insect control agents and methods of use |
12/30/1990 | CA2063260A1 Vasodilatory and immune suppressant peptides |
12/30/1990 | CA2020053A1 Hair growth composition |
12/28/1990 | WO1991000872A1 Monoclonal antibodies to c-reactive protein |
12/28/1990 | WO1991000290A1 Method of cleansing proteins |
12/27/1990 | WO1991000345A1 A mutated subtilisin protease |
12/27/1990 | WO1990015993A1 Assay for human ventricular myosin lc1 and monoclonal antibody thereto |
12/27/1990 | WO1990015877A2 Methods, compositions and devices for growing cells |
12/27/1990 | WO1990015876A1 Method for recovering recombinant proteins |
12/27/1990 | WO1990015873A1 Vector-mediated genomic insertion and expression of dna in bcg |
12/27/1990 | WO1990015871A1 Expression of tetanus toxin fragment c |
12/27/1990 | WO1990015867A1 Human prourokinase-like polypeptides and their preparation methods |
12/27/1990 | WO1990015818A1 Synthetic peptides for use in thrombus detection |
12/27/1990 | WO1990015817A1 Interferon purification process |
12/27/1990 | WO1990015815A1 Gamma retinoic acid receptor |
12/27/1990 | WO1990015798A1 Aminoalkyl maleimides and haptene and antigen derivatives thereof and conjugates with peptides or proteins |
12/27/1990 | WO1990015627A1 Methods and compositions for the preparation and use of site-directed immunologic reagents |
12/27/1990 | WO1990015624A1 Contraceptive vaccine based on cloned zona pellucida gene |
12/27/1990 | WO1990015621A1 A malaria vaccine |
12/27/1990 | WO1990015620A1 Platelet aggregation inhibitors |
12/27/1990 | WO1990015617A1 Albumin preparation and method of producing the same |
12/27/1990 | WO1990015615A1 The phospholipid binding domain of factor viii |
12/27/1990 | WO1990013314A3 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
12/27/1990 | EP0404750A1 Tissue inhibitor of metalloproteases (TIMP-2) |
12/27/1990 | EP0404660A2 Use of glycoprotein complex extracts of gram (-) bacteria for the preparation of a medicament to facilitate the cicatrisation of the skin and a method for its preparation |
12/27/1990 | EP0404652A1 Novel hypothalamic polypeptides with adenylate cyclase stimulating activity |
12/27/1990 | EP0404625A2 Oligonucleotide sequences for amplification of type HIV-2 and SIV retroviruses genomes and their application to in-vitro diagnostic of infections caused by these viruses |
12/27/1990 | EP0404576A2 Recombinant avipoxvirus |
12/27/1990 | EP0404546A2 Heteropolymeric protein production |
12/27/1990 | EP0404518A2 DNA probe for the identification of human parainfluenza type 2 virus |
12/27/1990 | EP0404458A2 Ovine follicle stimulating hormone |
12/27/1990 | EP0404210A2 A method and probe for the detection of cells associated with human oral medical disorders or with healthy human gingiva |
12/27/1990 | EP0404097A2 Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof |
12/27/1990 | EP0404055A1 Ghilanten: antimetastatic principle from the south american leech, haementeria ghilianii |
12/27/1990 | EP0404034A2 Novel DNA and use thereof |
12/27/1990 | EP0404003A2 Chimeric mouse-human KM10 antibody with specificity to a human tumor cell antigen |
12/27/1990 | EP0403961A2 Magnetic protein conjugates, process to make them and their use |
12/27/1990 | EP0403960A2 Magnetic protein conjugates, method to make them and their use |
12/27/1990 | EP0403828A1 Renin-inhibiting peptides, their preparation and their use in medicaments |
12/27/1990 | EP0403698A1 Eimeria tenella vaccine |
12/27/1990 | EP0403605A1 Elastase inhibiting polymers and methods |
12/27/1990 | EP0403601A1 Novel somatotropins. |
12/27/1990 | EP0403559A1 Improvements relating to antigens |